Influence of rabeprazole and famotidine on pharmacodynamic profile of dual antiplatelet therapy in clopidogrel-sensitive patients: The randomized, prospective, PROTECT trial

References

• Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, et al. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American college of cardiology foundation task force on expert consensus documents. J Am Coll Cardiol 2010;56:2051–2066. doi:10.1016/j.jacc.2010.09.010.
   PubMed Web of Science ®Google Scholar
• Steg PG, Huber K, Andreotti F, Arnesen H, Atar D, Badimon L, Bassand J-P, De Caterina R, Eikelboom JA, Gulba D, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the working group on thrombosis of the European society of cardiology. Eur Heart J 2011;32:1854–1864. doi:10.1093/eurheartj/ehr204.
   PubMed Web of Science ®Google Scholar
• Koskinas KC, Raber L, Zanchin T, Wenaweser P, Stortecky S, Moschovitis A, Khattab AA, Pilgrim T, Blöchlinger S, Moro C, et al. Clinical impact of gastrointestinal bleeding in patients undergoing percutaneous coronary interventions. Circ Cardiovasc Interv 2015;8(5). doi:10.1161/CIRCINTERVENTIONS.114.002053.
   PubMed Web of Science ®Google Scholar
• Ng FH, Tunggal P, Chu WM, Lam KF, Li A, Chan K, Lau Y-K, Kng C, Keung KK, Kwan A, et al. Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction. Am J Gastroenterol 2012;107:389–396. doi:10.1038/ajg.2011.385.
   PubMed Web of Science ®Google Scholar
• Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, Stone GW, Curzen N, Geisler T, Ten Berg J, et al. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol 2013;62:2261–2273. doi:10.1016/j.jacc.2013.07.101.
   PubMed Web of Science ®Google Scholar
• Tantry US, Kereiakes DJ, Gurbel PA. Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations. JACC Cardiovasc Interv 2011;4:365–380. doi:10.1016/j.jcin.2010.12.009.
   PubMed Web of Science ®Google Scholar
• Li XQ, Andersson TB, Ahlstrom M, Weidolf L. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug Metab Dispos 2004;32:821–827.
   PubMed Web of Science ®Google Scholar
• Funck-Brentano C, Szymezak J, Steichen O, Ducint D, Molimard M, Remones V, Azizi M, Gaussem P. Effects of rabeprazole on the antiplatelet effects and pharmacokinetics of clopidogrel in healthy volunteers. Arch Cardiovasc Dis 2013;106:661–671. doi:10.1016/j.acvd.2013.09.002.
   PubMed Web of Science ®Google Scholar
• Siriswangvat S, Sansanayudh N, Nathisuwan S, Panomvana D. Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel. Circ J 2010;74:2187–2192.
   PubMed Web of Science ®Google Scholar
• Taha AS, McCloskey C, Prasad R, Bezlyak V. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. Lancet 2009;374:119–125. doi:10.1016/S0140-6736(09)61246-0.
   PubMed Web of Science ®Google Scholar
• Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions. J Am Coll Cardiol 2011;58:e44–122. doi:10.1016/j.jacc.2011.08.007.
   PubMed Web of Science ®Google Scholar
• Gurbel PA, Antonino MJ, Bliden KP, Dichiara J, Suarez TA, Singla A, Tantry US. Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target. Platelets 2008;19:595–604. doi:10.1080/09537100802351065.
   PubMed Web of Science ®Google Scholar
• Park Y, Jeong YH, Tantry US, Ahn JH, Kim KH, Koh JS, Park J-R, Hwang S-J, Kwak CH, Hwang J-Y, et al. Effect of adjunctive dipyridamole to DAPT on platelet function profiles in stented patients with high platelet reactivity. The result of the ACCEL-DIP Study. Thromb Haemost 2014;112:1198–1208. doi:10.1160/TH14-01-0040.
   PubMed Web of Science ®Google Scholar
• Arbel Y, Birati EY, Finkelstein A, Halkin A, Kletzel H, Abramowitz Y, Berliner S, Deutsch V, Herz I, Keren G, et al. Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study. Clin Cardiol 2013;36:342–346. doi:10.1002/clc.22117.
   PubMed Web of Science ®Google Scholar
• El-Halabi MM, Zgheib N, Mansour NM, Malli A, Ghaith OA, Mahfouz R, Alam S, Sharara AI. CYP2C19 genetic polymorphism, rabeprazole and esomeprazole have no effect on the antiplatelet action of clopidogrel. J Cardiovasc Pharmacol 2013;62:41–49. doi:10.1097/FJC.0b013e31828ecf44.
   PubMed Web of Science ®Google Scholar
• Wu J, Jia LT, Shao LM, Chen JM, Zhong DD, Xu S, Cai J-T. Drug-drug interaction of rabeprazole and clopidogrel in healthy Chinese volunteers. Eur J Clin Pharmacol 2013;69:179–187. doi:10.1007/s00228-012-1329-z.
   PubMed Web of Science ®Google Scholar
• Ma C. Current antithrombotic treatment in East Asia: some perspectives on anticoagulation and antiplatelet therapy. Thromb Haemost 2012;107:1014–1018. doi:10.1160/TH11-04-0214.
   PubMed Web of Science ®Google Scholar
• Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, et al. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 2010;363:1909–1917. doi:10.1056/NEJMoa1007964.
   PubMed Web of Science ®Google Scholar
• Lanas A, Garcia-Rodriguez LA, Arroyo MT, Bujanda L, Gomollon F, Forne M, Aleman S, Nicolas D, Feu F, González-Pérez A, et al. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol 2007;102:507–515. doi:10.1111/j.1572-0241.2006.01062.x.
   PubMed Web of Science ®Google Scholar
• Hagymasi K, Mullner K, Herszenyi L, Tulassay Z. Update on the pharmacogenomics of proton pump inhibitors. Pharmacogenomics 2011;12:873–888. doi:10.2217/pgs.11.4.
   PubMed Web of Science ®Google Scholar
• Ogawa R, Echizen H. Drug-drug interaction profiles of proton pump inhibitors. Clin Pharmacokinet 2010;49:509–533. doi:10.2165/11531320-000000000-00000.
   PubMed Web of Science ®Google Scholar
• Sherwood MW, Melloni C, Jones WS, Washam JB, Hasselblad V, Dolor RJ. Individual proton pump inhibitors and outcomes in patients with coronary artery disease on dual antiplatelet therapy: A systematic review. J Am Heart Assoc 2015;4:11. doi:10.1161/JAHA.115.002245.
   Web of Science ®Google Scholar
• Niu Q, Wang Z, Zhang Y, Wang J, Zhang P, Wang C, Yin X, Hou Y. Combination use of clopidogrel and proton pump inhibitors increases major adverse cardiovascular events in patients with coronary artery disease: A meta-analysis. J Cardiovasc Pharmacol Ther 2017;22:142–152. doi:10.1177/1074248416663647.
   PubMed Web of Science ®Google Scholar
• Park Y, Jung JM, Tantry US, Kim K, Koh JS, Park JR, Hwang S-J, Kwak CH, Hwang J-Y, Kim S, et al. Pharmacodynamic effects of cilostazol versus clopidogrel in stented patients under proton pump inhibitor co-administration: the ACCEL-PARAZOL study. J Atheroscler Thromb 2014;21:1121–1139.
   PubMed Web of Science ®Google Scholar
• Agewall S, Cattaneo M, Collet JP, Andreotti F, Lip GY, Verheugt FW, Huber K, Grove EL, Morais J, Husted S, et al. Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy. Eur Heart J 2013;34:1708–1713,13a-13b. doi:10.1093/eurheartj/eht042.
   Web of Science ®Google Scholar
• Yamane K, Kato Y, Tazaki J, Tada T, Makiyama T, Imai M, Jinnai T, Ikeda T, Shirakawa R, Kimura T, et al. Effects of PPIs and an H2 blocker on the antiplatelet function of clopidogrel in Japanese patients under dual antiplatelet therapy. J Atheroscler Thromb 2012;19:559–569.
   PubMed Web of Science ®Google Scholar
• Lin KJ, Hernandez-Diaz S, Garcia Rodriguez LA. Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy. Gastroenterology 2011;141:71–79. doi:10.1053/j.gastro.2011.03.049.
   PubMed Web of Science ®Google Scholar
• Chan FK, Kyaw M, Tanigawa T, Higuchi K, Fujimoto K, Cheong PK, Lee V, Kinoshita Y, Naito Y, Watanabe T, et al. Similar efficacy of proton-pump inhibitors vs H2-receptor antagonists in reducing risk of upper gastrointestinal bleeding or ulcers in high-risk users of low-dose aspirin. Gastroenterology 2017;152:105–110 e1. doi:10.1053/j.gastro.2016.09.006.
   PubMed Web of Science ®Google Scholar
• Campo G, Parrinello G, Ferraresi P, Lunghi B, Tebaldi M, Miccoli M, Marchesini J, Bernardi F, Ferrari R, Valgimigli M. Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome. J Am Coll Cardiol 2011;57:2474–2483. doi:10.1016/j.jacc.2010.12.047.
   PubMed Web of Science ®Google Scholar
• Stone GW, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri E, et al. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study. Lancet 2013;382:614–623. doi:10.1016/S0140-6736(13)61170-8.
   PubMed Web of Science ®Google Scholar